Wells Fargo’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $12M | Sell |
|
|||||
|
2025
Q1 | $70.4M | Sell |
|
|||||
|
2024
Q4 | $89.3M | Sell |
|
|||||
|
2024
Q3 | $109M | Sell |
|
|||||
|
2024
Q2 | $116M | Sell |
|
|||||
|
2024
Q1 | $154M | Buy |
|
|||||
|
2023
Q4 | $129M | Sell |
|
|||||
|
2023
Q3 | $112M | Buy |
|
|||||
|
2023
Q2 | $114M | Buy |
|
|||||
|
2023
Q1 | $103M | Buy |
|
|||||
|
2022
Q4 | $102M | Sell |
|
|||||
|
2022
Q3 | $95.4M | Buy |
|
|||||
|
2022
Q2 | $99.3M | Sell |
|
|||||
|
2022
Q1 | $139M | Buy |
|
|||||
|
2021
Q4 | $129M | Buy |
|
|||||
|
2021
Q3 | $128M | Sell |
|
|||||
|
2021
Q2 | $120M | Sell |
|
|||||
|
2021
Q1 | $115M | Sell |
|
|||||
|
2020
Q4 | $130M | Sell |
|
|||||
|
2020
Q3 | $230M | Sell |
|
|||||
|
2020
Q2 | $209M | Buy |
|
|||||
|
2020
Q1 | $143M | Sell |
|
|||||
|
2019
Q4 | $186M | Sell |
|
|||||
|
2019
Q3 | $164M | Buy |
|
|||||
|
2019
Q2 | $147M | Sell |
|
|||||
|
2019
Q1 | $152M | Sell |
|
|||||
|
2018
Q4 | $167M | Buy |
|
|||||
|
2018
Q3 | $188M | Buy |
|
|||||
|
2018
Q2 | $148M | Buy |
|
|||||
|
2018
Q1 | $133M | Buy |
|
|||||
|
2017
Q4 | $26.1M | Buy |
|
|||||
|
2017
Q3 | $9.28M | Buy |
|
|||||
|
2017
Q2 | $8.2M | Buy |
|
|||||
|
2017
Q1 | $4.39M | Sell |
|
|||||
|
2016
Q4 | $5.15M | Buy |
|
|||||
|
2016
Q3 | $5.04M | Sell |
|
|||||
|
2016
Q2 | $5.32M | Sell |
|
|||||
|
2016
Q1 | $6.85M | Buy |
|
|||||
|
2015
Q4 | $4.86M | Sell |
|
|||||
|
2015
Q3 | $17.2M | Sell |
|
|||||
|
2015
Q2 | $19.2M | Sell |
|
|||||
|
2015
Q1 | $23.3M | Sell |
|
|||||
|
2014
Q4 | $30.7M | Sell |
|
|||||
|
2014
Q3 | $30.1M | Sell |
|
|||||
|
2014
Q2 | $34.7M | Sell |
|
|||||
|
2014
Q1 | $41.5M | Sell |
|
|||||
|
2013
Q4 | $43M | Buy |
|
|||||
|
2013
Q3 | $32.5M | Buy |
|
|||||
|
2013
Q2 | $25M | Buy |
|